Affimed Announces Updated Data of AFM13 in Combination with Keytruda® (Pembrolizumab) in Patients with Relapsed/Refractory Hodgkin Lymphoma Presented at EHA
June 15, 2018
June 15, 2018
May 30, 2018
May 18, 2018
May 15, 2018
May 8, 2018
May 3, 2018
May 3, 2018
April 16, 2018
March 20, 2018
March 19, 2018